Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: fight malaria + plasmodium vivax + malaria  Related to the article below (Last Update: 5/5/2008)


Sydney Morning Herald
Mosquito George fights to put malaria in the net
Sydney Morning Herald, Australia - Apr 24, 2008
In PNG, the two parasites responsible for causing malaria are plasmodium falciparum and plasmodium vivax. "About 50 per cent of people get falciparum, ...

The Daily Star
Bangladesh stands with all
The Daily Star, Bangladesh - Apr 25, 2008
It is caused by a parasite called Plasmodium transmitted by female Anopheles mosquitoes. Four species of plasmodia cause human malaria: P. vivax, ...
AFGHANISTAN: Over half the population at risk of malaria - Health ...
Reuters AlertNet, UK - Apr 26, 2008
MoPH says that 14 of the country's 34 provinces are identified as "high risk" areas where, plasmodium vivax, a malaria parasite, is prevalent. ...
Source: Google News

… of the OptiMAL Test for Rapid Diagnosis of Plasmodium vivax and Plasmodium falciparum Malaria -
CJ Palmer, JF Lindo, WI Klaskala, JA Quesada, R … - Journal of Clinical Microbiology, 1998 - jcm.highwire.org
... that could be invaluable in the fight to control ... Field Evaluation of the ICT Malaria
Pf/Pv ... Detection of Plasmodium falciparum and Plasmodium vivax in Patients ...

articles Genome sequence of the human malaria parasite Plasmodium falciparum -
MJ Gardner, N Hall, E Fung, O White, M Berriman, … - Nature, 2002 - palgrave-journals.com
... begin genome sequencing efforts for Plasmodium vivax, the second ... The increased attention
given to malaria (and to ... the Global Fund to Fight AIDS, Tuberculosis ...

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum … -
SL Hoffman, LM Goh, TC Luke, I Schneider, TP Le, … - J Infect Dis, 2002 - UChicago Press
... Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with
sporozoite ... for the development of an engineered sporozoite malaria vaccine. ...

The Plasmodium vivax genome sequencing project -
J Carlton - Trends in Parasitology, 2003 - Elsevier
... A landmark in the fight against malaria was passed ... of a model rodent malaria parasite
Plasmodium yoelii yoelii ... data from other species of malaria parasite are ...

Malaria drug-sensitivity testing: new assays, new perspectives -
H Noedl, C Wongsrichanalai, WH Wernsdorfer - Trends in Parasitology, 2003 - Elsevier
... as chemotherapy remains a key factor in the fight against malaria ... Plasmodium vivax. ...
produce a clinical, parasitological cure of an acute attack of vivax malaria. ...

Genetic susceptibility to malaria getting complex -
D Kwiatkowski - Current Opinion in Genetics & Development, 2000 - Elsevier
... parasites, of which Plasmodium falciparum and Plasmodium vivax are the ... to develop
a liver-stage malaria vaccine [19 ... the pathogen, does the parasite fight back? ...

Malaria: burden of disease -
C Guinovart, MM Navia, M Tanner, PL Alonso - Curr Mol Med, 2006 - ingentaconnect.com
... cases in this region are caused by Plasmodium falciparum, and ... Back Malaria, the Global
Fund to fight AIDS, Tuberculosis and Malaria, the Medicines ...

[PDF] Drug resistance in malaria -
PB Bloland - World Health Organization, Geneva, 2001 - who.int
... In humans, malaria infection is caused by one or more of four species of intracellular
protozoan para- site. Plasmodium falciparum, P. vivax, P. ovale, and P ...

Malaria vaccine developments -
VS Moorthy, MF Good, AVS Hill - The Lancet, 2004 - Elsevier
... Pvs=Plasmodium vivax surface protein. ... Global Alliance for Vaccines and Immunisation;
the Global Fund to Fight AIDS, Tuberculosis and Malaria; or a ...

Diagnosis and Treatment of Malaria in Children -
W Stauffer, PR Fischer - Clinical Infectious Diseases, 2003 - UChicago Press
... 55th World Health Assembly. Global Fund to Fight AIDS, Tuberculosis and Malaria. ...
Local transmission of Plasmodium vivax malaria?Virginia 2002. ...

Source: Google Scholar

Fight Malaria Caused By Plasmodium Vivax
The CRESIB has presented the research programme on malaria by Plasmodium vivax, a parasite causing over 70 million yearly cases of malaria in the world. This new programme will be developed in coordination with the leading international centres and researchers on P.vivax. The aim of this study is to contribute to a better understanding of malaria by P. vivax and to support and accelerate the development of new control tools, with a special focus in vaccines. This fact will promote the creation and development of a research line on P. vivax in CRESIB under the direction of Dr. Hernando A. del Portillo, one of the few specialists in molecular biology and vaccine development against this parasite. The number of CRESIB labs will be increased, with an enlargement and restoration of current facilities to meet the needs of the centre.
Malaria is an infectious disease which can be caused by four species of the Plasmodium parasite: P. falciparum, P. vivax, P. malariae and P. ovale. P. falciparum and P. vivax are the most prevalent, the first being more virulent and responsible of most of the severe morbidity and mortality. Nevertheless, during the last years, there has been a growing interest in malaria by P. vivax, which, as well as causing millions of malaria cases every year, it also generates a high social and economic cost for endemic countries. It is estimated that about 2,600 million people live in risk zones for P. vivax: central and south-America, Asia, Middle East and occidental Pacific. Clinical and pathogen presentation of P. vivax is not well understood. Despite the traditional belief that clinical malaria caused by this species of the parasite is mild, there are evidences suggesting that it can cause severe clinical patterns and even death of patients.

The paradox is that even though malaria by P. vivax has large global disease burden, this is a poorly studied disease, which has been long forgotten. Consequently, this new research programme has a large importance, and an estimated initial duration of 4 years.

This is the reason why CRESIB, through DR. Hernando A. del Portillo, specialist in molecular biology and vaccine development against Plasmodium vivax, gives plenty of importance to the development of new control tools for this type of malaria.

In the field of malaria by P. vivax, there has been until now a lack of initiatives to promote the global effort in the research on this disease. With the experience of the CRESIB group in malaria and of the Clínic Foundation for Biomedical Research (FCRB, Fundació Clínic per a la Recerca Biomèdica) in the management and coordination of projects of international research, an international consortium of research in P. vivax will be created and promoted. This consortium will be constituted by leading malaria research centres, and will be coordinated from Barcelona.

Research centres collaborating in this project, mostly placed in malaria endemic areas by Plasmodium vivax, are: Papua New Guinea Institute of Medical Research, located in Papua New Guinea; the International Centre for Genetic Engineering and Biotechnology, located in New Delhi (India), the Tropical Medicine Foundation of Amazonas, in Manaus (Brazil) and the International Vaccine Centre, located in Cali (Colombia).

About CRESIB: Research on poverty-related diseases is one of our main tools to try to break the vicious circle between disease and poverty and to have an impact on the development of low-income countries. It is in this sense that the CRESIB has been created in Catalonia, an institute born from the scientific support of the International Health Centre of Hospital Clínic and founded by the Catalan Government through the Department of Health and the Department of Innovation, Universities and Enterprises; the Universitat de Barcelona(UB); the Hospital Clínic de Barcelona; and the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) with the objective to conduct excellence research in international health and to contribute to the global effort in the fight against poverty-related diseases.
CRESIB has a scientific programme including research on diseases causing an important part of the morbidity and mortality in low-income countries, specially malaria, acute respiratory infections, diarrhoeas, tuberculosis and AIDS. Furthermore, CRESIB sets its sights on promoting research related to other aspects of international health, such as emergent, reemergent and immunopreventable diseases, health, immigration and climate and health. Research conducted by CRESIB researchers is currently developed in the facilities located in the Campus of the Faculty of Medicine of the Universitat de Barcelona-Hospital Clínic.

Department of Communication and External Relations of the IDIBAPS - Hospital Clínic of Barcelona

For further information, please contact us at http://www.cresib.cat/

Source: Marc de Semir
IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.